Site icon Healthcare, Lifestyle, Entertainment, Living and Travel

Summit stock soars as lung cancer drug beats Merck’s Keytruda in late-stage trial



Summit stock soars as lung cancer drug beats Merck’s Keytruda in late-stage trial



Source: Seekingalpha

Exit mobile version